> Gamida Cell teamed up with Editas Medicine to apply CRISPR to natural killer cells expanded using its nicotinamide-based technology. The partners hope the work will lead to treatments for cancers. Release
> Helsinn Investment Fund put €1 million ($1.1 million) into Gain Therapeutics, a Swiss startup with a technology for identifying small molecules that penetrate the brain. Statement
> Autolus posted updated data on its CAR-T AUTO1 in children with acute lymphoblastic leukemia. A single dose of AUTO1 triggered molecular complete responses in 86% of subjects. Release
> Calypso Biotech raised a €20 million series A round. The Dutch biotech will use the money to take an anti-IL-15 autoimmune disease drug into the clinic. Statement
> The University of Dundee Drug Discovery Unit struck a deal with Takeda to develop treatments for Alzheimer’s disease and other neurodegenerative conditions involving tau. Release
> Affibody completed enrollment in a phase 2 psoriasis trial. Statement